Review





Similar Products

99
Dojindo Labs nad turnover
Nad Turnover, supplied by Dojindo Labs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistics+program+sigmaplot+v%2E+11+or+13/Cell+Counting+Kit-8/pmc13004575-101-11-8
Average 99 stars, based on 1 article reviews
nad turnover - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

99
Dojindo Labs viability
Viability, supplied by Dojindo Labs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistics+program+sigmaplot+v%2E+11+or+13/Cell+Counting+Kit-8/pmc13004575-101-0-8
Average 99 stars, based on 1 article reviews
viability - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

99
Dojindo Labs cell counting kit 8
Cell Counting Kit 8, supplied by Dojindo Labs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistics+program+sigmaplot+v%2E+11+or+13/Cell+Counting+Kit-8/pmc13004575-101-4-8
Average 99 stars, based on 1 article reviews
cell counting kit 8 - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

99
Dojindo Labs cell counting kit 8 assay
Cell Counting Kit 8 Assay, supplied by Dojindo Labs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistics+program+sigmaplot+v%2E+11+or+13/Cell+Counting+Kit-8/pm42892943-101-11-16
Average 99 stars, based on 1 article reviews
cell counting kit 8 assay - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

99
Dojindo Labs cck 8 reagent
Cck 8 Reagent, supplied by Dojindo Labs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistics+program+sigmaplot+v%2E+11+or+13/Cell+Counting+Kit-8/pm42891822-58-3-5
Average 99 stars, based on 1 article reviews
cck 8 reagent - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

99
PCR Biosystems Ltd qpcrbio sygreen mix
Qpcrbio Sygreen Mix, supplied by PCR Biosystems Ltd, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistics+program+sigmaplot+v%2E+11+or+13/qPCRBIO+SyGreen+Mix+Lo-ROX/pm42889706-891-66-69
Average 99 stars, based on 1 article reviews
qpcrbio sygreen mix - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

99
STATA Corporation stata version 13
Stata Version 13, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistics+program+sigmaplot+v%2E+11+or+13/STATA+13%2E0/pm42888407-77-6-6
Average 99 stars, based on 1 article reviews
stata version 13 - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

99
Dojindo Labs cell counting kit 8 cck 8 assay
a Quantification of percentage of cells in G 0/ G 1 , S, and G2/M cell cycle phases under control, IL-1β, IL-1β + IL-1Ra, and IL-1Ra treatment conditions for 24 h and 72 h treatments in MCF-7 cells through flow cytometry. <t>b</t> <t>CCK-8</t> assay results for control, IL-1β, IL-1β + IL-1Ra and IL-1Ra treatment conditions for 24 h and 72 h treatments in MCF-7 cells. c EdU incorporation assay in MCF-7 cells to measure DNA synthesis for control, IL-1β, IL-1β + IL-1Ra and IL-1Ra treatment conditions for 24 h and 72 h in MCF-7 cells. For statistical significance assessment Two-way ANOVA with Tukey’s multiple comparisons test was used for cell cycle analysis and ordinary one-way ANOVA with Tukey’s multiple comparisons test was used for CCK8 and EdU assays (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001). d Quantification of apoptotic stages post 24 h and 72 h treatments in MCF-7 cells for control, IL-1β, IL-1β + IL-1Ra and IL-1Ra treatment conditions. e Quantification of intracellular ROS measured as DCFDA mean fluorescence intensity (MFI) post IL-1β treatment for 24 and 72 h. One-way ANOVA with Tukey’s multiple comparisons test was used for significance testing (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001). f Representative images of SA-β-gal staining for control, IL-1β, IL-1β + IL-1Ra, and IL-1Ra treated MCF-7 cells post treatment for 72 h and quantification of senescence-associated β-galactosidase (SA-β-gal) positivity. At least 100 cells per field were manually counted across ten random fields (10×), and the percentage of SA-β-gal–positive cells was calculated as the mean across fields. Statistical significance was assessed using ordinary one-way ANOVA with Tukey’s multiple comparisons test (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001). g Flow cytometric analysis of cellular senescence using the CellEvent™ Senescence Green assay. Median fluorescence intensity (X-Med) of the gated Senescence Green-positive population in control, IL-1β, IL-1β + IL-1Ra, and IL-1Ra-treated MCF-7 cells following 72 h of treatment was used for measuring senescence. One-way ANOVA with Tukey’s multiple comparisons test was used for significance testing (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001)
Cell Counting Kit 8 Cck 8 Assay, supplied by Dojindo Labs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistics+program+sigmaplot+v%2E+11+or+13/Cell+Counting+Kit-8/pmc13676678-62-0-5
Average 99 stars, based on 1 article reviews
cell counting kit 8 cck 8 assay - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

Image Search Results


a Quantification of percentage of cells in G 0/ G 1 , S, and G2/M cell cycle phases under control, IL-1β, IL-1β + IL-1Ra, and IL-1Ra treatment conditions for 24 h and 72 h treatments in MCF-7 cells through flow cytometry. b CCK-8 assay results for control, IL-1β, IL-1β + IL-1Ra and IL-1Ra treatment conditions for 24 h and 72 h treatments in MCF-7 cells. c EdU incorporation assay in MCF-7 cells to measure DNA synthesis for control, IL-1β, IL-1β + IL-1Ra and IL-1Ra treatment conditions for 24 h and 72 h in MCF-7 cells. For statistical significance assessment Two-way ANOVA with Tukey’s multiple comparisons test was used for cell cycle analysis and ordinary one-way ANOVA with Tukey’s multiple comparisons test was used for CCK8 and EdU assays (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001). d Quantification of apoptotic stages post 24 h and 72 h treatments in MCF-7 cells for control, IL-1β, IL-1β + IL-1Ra and IL-1Ra treatment conditions. e Quantification of intracellular ROS measured as DCFDA mean fluorescence intensity (MFI) post IL-1β treatment for 24 and 72 h. One-way ANOVA with Tukey’s multiple comparisons test was used for significance testing (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001). f Representative images of SA-β-gal staining for control, IL-1β, IL-1β + IL-1Ra, and IL-1Ra treated MCF-7 cells post treatment for 72 h and quantification of senescence-associated β-galactosidase (SA-β-gal) positivity. At least 100 cells per field were manually counted across ten random fields (10×), and the percentage of SA-β-gal–positive cells was calculated as the mean across fields. Statistical significance was assessed using ordinary one-way ANOVA with Tukey’s multiple comparisons test (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001). g Flow cytometric analysis of cellular senescence using the CellEvent™ Senescence Green assay. Median fluorescence intensity (X-Med) of the gated Senescence Green-positive population in control, IL-1β, IL-1β + IL-1Ra, and IL-1Ra-treated MCF-7 cells following 72 h of treatment was used for measuring senescence. One-way ANOVA with Tukey’s multiple comparisons test was used for significance testing (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001)

Journal: Inflammation Research

Article Title: IL-1β/IL-6 inflammatory crosstalk drives DNA methylation and histone remodeling associated with cytokine induced senescence in luminal breast cancer

doi: 10.1007/s00011-026-02391-7

Figure Lengend Snippet: a Quantification of percentage of cells in G 0/ G 1 , S, and G2/M cell cycle phases under control, IL-1β, IL-1β + IL-1Ra, and IL-1Ra treatment conditions for 24 h and 72 h treatments in MCF-7 cells through flow cytometry. b CCK-8 assay results for control, IL-1β, IL-1β + IL-1Ra and IL-1Ra treatment conditions for 24 h and 72 h treatments in MCF-7 cells. c EdU incorporation assay in MCF-7 cells to measure DNA synthesis for control, IL-1β, IL-1β + IL-1Ra and IL-1Ra treatment conditions for 24 h and 72 h in MCF-7 cells. For statistical significance assessment Two-way ANOVA with Tukey’s multiple comparisons test was used for cell cycle analysis and ordinary one-way ANOVA with Tukey’s multiple comparisons test was used for CCK8 and EdU assays (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001). d Quantification of apoptotic stages post 24 h and 72 h treatments in MCF-7 cells for control, IL-1β, IL-1β + IL-1Ra and IL-1Ra treatment conditions. e Quantification of intracellular ROS measured as DCFDA mean fluorescence intensity (MFI) post IL-1β treatment for 24 and 72 h. One-way ANOVA with Tukey’s multiple comparisons test was used for significance testing (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001). f Representative images of SA-β-gal staining for control, IL-1β, IL-1β + IL-1Ra, and IL-1Ra treated MCF-7 cells post treatment for 72 h and quantification of senescence-associated β-galactosidase (SA-β-gal) positivity. At least 100 cells per field were manually counted across ten random fields (10×), and the percentage of SA-β-gal–positive cells was calculated as the mean across fields. Statistical significance was assessed using ordinary one-way ANOVA with Tukey’s multiple comparisons test (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001). g Flow cytometric analysis of cellular senescence using the CellEvent™ Senescence Green assay. Median fluorescence intensity (X-Med) of the gated Senescence Green-positive population in control, IL-1β, IL-1β + IL-1Ra, and IL-1Ra-treated MCF-7 cells following 72 h of treatment was used for measuring senescence. One-way ANOVA with Tukey’s multiple comparisons test was used for significance testing (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001)

Article Snippet: Cell counting kit-8 (CCK-8) assay (Dojindo, Japan) was used to assess proliferative effects of cytokine induction on MCF-7 breast cancer cells.

Techniques: Control, Flow Cytometry, CCK-8 Assay, EdU Assay, DNA Synthesis, Cell Cycle Assay, Fluorescence, Staining, Analysis

a CCK-8 and b EdU incorporation assays demonstrating increased proliferation and DNA synthesis following IL-1β conditioned media (CM) treatment, with partial reversal by IL-1Ra or IL-6R blockade. Ordinary one-way ANOVA with Tukey’s multiple comparisons test was used to assess significance (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001). c Quantification of percentage of cells in G 0/ G 1 , S, and G2/M cell cycle phases in naïve recipient MCF-7 cells following 24-hour treatment with conditioned media from the indicated treatment groups, including IL-1β-derived conditioned media with or without huE17 through flow cytometry. Two-way ANOVA with Tukey’s multiple comparisons test was used for cell cycle analysis to determine statistical significance. d Soft agar colony formation assay to assess anchorage-independent growth under IL-1β CM, attenuated by IL-1Ra or antibody treatment conditions and quantification of mean colony diameter. One-way ANOVA with Dunnett’s test was used for significance (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001)

Journal: Inflammation Research

Article Title: IL-1β/IL-6 inflammatory crosstalk drives DNA methylation and histone remodeling associated with cytokine induced senescence in luminal breast cancer

doi: 10.1007/s00011-026-02391-7

Figure Lengend Snippet: a CCK-8 and b EdU incorporation assays demonstrating increased proliferation and DNA synthesis following IL-1β conditioned media (CM) treatment, with partial reversal by IL-1Ra or IL-6R blockade. Ordinary one-way ANOVA with Tukey’s multiple comparisons test was used to assess significance (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001). c Quantification of percentage of cells in G 0/ G 1 , S, and G2/M cell cycle phases in naïve recipient MCF-7 cells following 24-hour treatment with conditioned media from the indicated treatment groups, including IL-1β-derived conditioned media with or without huE17 through flow cytometry. Two-way ANOVA with Tukey’s multiple comparisons test was used for cell cycle analysis to determine statistical significance. d Soft agar colony formation assay to assess anchorage-independent growth under IL-1β CM, attenuated by IL-1Ra or antibody treatment conditions and quantification of mean colony diameter. One-way ANOVA with Dunnett’s test was used for significance (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001)

Article Snippet: Cell counting kit-8 (CCK-8) assay (Dojindo, Japan) was used to assess proliferative effects of cytokine induction on MCF-7 breast cancer cells.

Techniques: CCK-8 Assay, EdU Assay, DNA Synthesis, Derivative Assay, Flow Cytometry, Cell Cycle Assay, Soft Agar Assay, Colony Assay, Tube Formation Assay